Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

An automated fluorometric microculture cytotoxicity assay (FMCA) based on the measurement of fluorescence generated from cellular hydrolysis of fluorescein diacetate (FDA) to fluorescein was employed for chemotherapeutic‐drug‐sensitivity testing of tumor‐cell suspensions from patients with leukemia. Fluorescence was linearly related to cell number, and reproducible measurements of drug sensitivity could be performed using fresh or cryopreserved leukemia cells. A marked heterogeneity with respect to chemotherapeutic drug sensitivity was observed for a panel of cytotoxic drugs tested in 43 samples from 35 patients with treated or untreated acute and chronic leukemia. For samples obtained from patients with chronic lymphocytic and acute myelocytic leukemia, sensitivity profiles for standard drugs corresponded to known clinical activity and the assay detected primary and acquired drug resistance. Individual in vitro/in vivo correlations indicated high specificity with respect to the identification of drug resistance. The results suggest that the FMCA may be a simple and rapid method for in vivo‐representative determinations of chemotherapeutic drug resistance in tumor cells obtained from patients with leukemia.

[1]  R. Larsson,et al.  Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators , 1991, International Journal of Cancer.

[2]  C. Taylor,et al.  Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. , 1989, British Journal of Cancer.

[3]  T. Kubota,et al.  Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay , 1989, Journal of surgical oncology.

[4]  A. G. Bosanquet,et al.  Long‐term comparison of results of a drug sensitivity assay in vitro with patient response in lymphatic neoplasms , 1988, Cancer.

[5]  T. Hongo,et al.  An in vitro chemosensitivity test for the screening of anti‐cancer drugs in childhood leukemia , 1990, Cancer.

[6]  I. Viano,et al.  In vitro chemosensitivity testing of leukemic cells: Prediction of response to chemotherapy in patients with acute non‐lymphocytic leukemia , 1989, Hematological oncology.

[7]  R. Larsson,et al.  Pharmacological modification of multi‐drug resistance (mdr) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin a and verapamil on mdr leukemia t‐cells , 1990, International journal of cancer.

[8]  R. Larsson,et al.  A rapid fluorometric method for semiautomated determination of cytotoxicity and cellular proliferation of human tumor cell lines in microculture. , 1989, Anticancer research.

[9]  Alberts Ds,et al.  Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. , 1980 .

[10]  T. Kubota,et al.  MTT assay with reference to the clinical effect of chemotherapy , 1989, Journal of surgical oncology.

[11]  D. Kern,et al.  Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures. , 1990, Journal of the National Cancer Institute.

[12]  N. Fox,et al.  Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay , 1989, British journal of haematology.

[13]  A. G. Bosanquet,et al.  In vitro determination of tumour chemosensitivity in haematological malignancies , 1985, Hematological oncology.

[14]  V. Sondak,et al.  Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. , 1985, Cancer research.

[15]  D. Kirkpatrick,et al.  Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. , 1990, Leukemia research.

[16]  R. Larsson,et al.  Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay. , 1990, Leukemia.

[17]  B. Teicher,et al.  Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. , 1990, Science.

[18]  R. Pieters,et al.  Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. , 1989, British Journal of Cancer.

[19]  C. Paul,et al.  In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations , 1989, European journal of haematology.

[20]  L. Weisenthal,et al.  Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. , 1983, Cancer research.

[21]  P. Calabresi,et al.  Chemotherapy of neoplastic diseases. , 1962, Annual review of medicine.

[22]  A. G. Bosanquet.  Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay , 1991, The Lancet.